End-of-day quote
Colombo S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
64.9
LKR
|
-0.92%
|
|
+5.36%
|
+27.25%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
5,668
|
11,890
|
16,421
|
22,139
|
31,929
|
-
|
Enterprise Value (EV)
1 |
5,668
|
11,890
|
16,421
|
22,139
|
31,929
|
31,929
|
P/E ratio
|
4.94
x
|
7.82
x
|
6.04
x
|
9.64
x
|
-
|
-
|
Yield
|
-
|
6.6%
|
-
|
-
|
3.08%
|
4.78%
|
Capitalization / Revenue
|
0.27
x
|
0.49
x
|
-
|
-
|
0.57
x
|
0.51
x
|
EV / Revenue
|
0.27
x
|
0.49
x
|
-
|
-
|
0.57
x
|
0.51
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.13
x
|
-
|
-
|
1.79
x
|
1.43
x
|
Nbr of stocks (in thousands)
|
448,662
|
448,662
|
448,662
|
491,974
|
491,974
|
-
|
Reference price
2 |
12.63
|
26.50
|
36.60
|
45.00
|
64.90
|
64.90
|
Announcement Date
|
20-05-27
|
21-05-31
|
22-05-30
|
23-05-25
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
20,831
|
24,339
|
-
|
-
|
55,979
|
62,230
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
3,669
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
15.07%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
3,309
|
-
|
-
|
-
|
-
|
Net income
|
-
|
1,520
|
2,721
|
2,264
|
-
|
-
|
Net margin
|
-
|
6.25%
|
-
|
-
|
-
|
-
|
EPS
|
2.557
|
3.390
|
6.060
|
4.670
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
1.750
|
-
|
-
|
2.000
|
3.100
|
Announcement Date
|
20-05-27
|
21-05-31
|
22-05-30
|
23-05-25
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
17.2%
|
-
|
-
|
25.2%
|
25.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
-
|
23.50
|
-
|
-
|
36.30
|
45.50
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-05-27
|
21-05-31
|
22-05-30
|
23-05-25
|
-
|
-
|
Last Close Price
64.9
LKR Average target price
81.15
LKR Spread / Average Target +25.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.25% | 107M | | -34.16% | 14.83B | | -24.55% | 12.04B | | +14.96% | 6.44B | | -25.24% | 6.52B | | -8.01% | 6.15B | | -2.34% | 4.64B | | +60.00% | 4.62B | | -8.10% | 3.93B | | -11.16% | 3.49B |
Other Drug Retailers
|